These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 15894066

  • 1. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
    Gorriti MA, Ferrer B, del Arco I, Bermúdez-Silva FJ, de Diego Y, Fernandez-Espejo E, Navarro M, Rodríguez de Fonseca F.
    Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
    [Abstract] [Full Text] [Related]

  • 2. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K.
    Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
    [Abstract] [Full Text] [Related]

  • 3. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
    Verty AN, McGregor IS, Mallet PE.
    Brain Res; 2004 Sep 10; 1020(1-2):188-95. PubMed ID: 15312802
    [Abstract] [Full Text] [Related]

  • 4. Behavioral effects of the novel cannabinoid full agonist AM 411.
    McLaughlin PJ, Lu D, Winston KM, Thakur G, Swezey LA, Makriyannis A, Salamone JD.
    Pharmacol Biochem Behav; 2005 May 10; 81(1):78-88. PubMed ID: 15894067
    [Abstract] [Full Text] [Related]

  • 5. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
    De Vry J, Jentzsch KR.
    Behav Pharmacol; 2003 Sep 10; 14(5-6):471-6. PubMed ID: 14501260
    [Abstract] [Full Text] [Related]

  • 6. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
    Akhisaroglu M, Kurtuncu M, Manev H, Uz T.
    Pharmacol Biochem Behav; 2005 Mar 10; 80(3):371-7. PubMed ID: 15740778
    [Abstract] [Full Text] [Related]

  • 7. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct 10; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 8. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
    Célérier E, Ahdepil T, Wikander H, Berrendero F, Nyberg F, Maldonado R.
    Neuropharmacology; 2006 Jun 10; 50(7):788-806. PubMed ID: 16443242
    [Abstract] [Full Text] [Related]

  • 9. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
    Singh ME, McGregor IS, Mallet PE.
    Neuropharmacology; 2005 Dec 10; 49(8):1189-200. PubMed ID: 16137723
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K, Mishima K, Hazekawa M, Sano K, Irie K, Orito K, Egawa T, Kitamura Y, Uchida N, Nishimura R, Egashira N, Iwasaki K, Fujiwara M.
    Brain Res; 2008 Jan 10; 1188():157-64. PubMed ID: 18021759
    [Abstract] [Full Text] [Related]

  • 11. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?
    Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M.
    Mol Pharmacol; 2005 May 10; 67(5):1697-704. PubMed ID: 15710746
    [Abstract] [Full Text] [Related]

  • 12. CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited.
    Jardinaud F, Crété D, Canestrelli C, Ledent C, Roques BP, Noble F.
    Brain Res; 2005 Nov 23; 1063(1):77-83. PubMed ID: 16256959
    [Abstract] [Full Text] [Related]

  • 13. Different effects of chronic THC on the neuroadaptive response of dopamine D2/3 receptor-mediated signaling in roman high- and roman low-avoidance rats.
    Tournier BB, Dimiziani A, Tsartsalis S, Millet P, Ginovart N.
    Synapse; 2018 Apr 23; 72(4):. PubMed ID: 29265497
    [Abstract] [Full Text] [Related]

  • 14. Neonatal immune system activation with lipopolysaccharide enhances behavioural sensitization to the dopamine agonist, quinpirole, in adult female but not male rats.
    Tenk CM, Foley KA, Kavaliers M, Ossenkopp KP.
    Brain Behav Immun; 2007 Oct 23; 21(7):935-45. PubMed ID: 17449223
    [Abstract] [Full Text] [Related]

  • 15. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
    Whitlow CT, Freedland CS, Porrino LJ.
    Psychopharmacology (Berl); 2002 May 23; 161(2):129-36. PubMed ID: 11981592
    [Abstract] [Full Text] [Related]

  • 16. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
    Moreno M, Lopez-Moreno JA, Rodríguez de Fonseca F, Navarro M.
    Behav Pharmacol; 2005 Sep 23; 16(5-6):441-6. PubMed ID: 16148449
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system.
    Zarrindast MR, Sarahroodi S, Arzi A, Khodayar MJ, Taheri-Shalmani S, Rezayof A.
    Behav Pharmacol; 2008 Oct 23; 19(7):716-23. PubMed ID: 18797248
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M, Dekeyne A, Papp M, Millan MJ.
    Behav Pharmacol; 2006 Nov 23; 17(7):559-72. PubMed ID: 17021388
    [Abstract] [Full Text] [Related]

  • 19. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus.
    Kochman LJ, dos Santos AA, Fornal CA, Jacobs BL.
    Brain Res; 2006 Oct 03; 1113(1):86-93. PubMed ID: 16930565
    [Abstract] [Full Text] [Related]

  • 20. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
    Amal H, Fridman-Rozevich L, Senn R, Strelnikov A, Gafni M, Keren O, Sarne Y.
    Behav Brain Res; 2010 Jan 20; 206(2):245-53. PubMed ID: 19766676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.